Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Hepatology. 2018 Sep 20;68(6):2230–2238. doi: 10.1002/hep.30094

Table 1.

Characteristics of NAFLD patients and matched controls.

Controls
N=108,420
NAFLD
N=108,420
Age (years)
 Median (IQR) 55 (45–65) 55 (45–65)
Age groups (years)
 18–34 9,341 (8.6%) 9,341 (8.6%)
 35–54 43,599 (40.2%) 43,599 (40.2%)
 55–64 28,147 (26.0%) 28,147 (26.0%)
 ≥65 27,333 (25.2%) 27,333 (25.2%)
Gender
 Female 57,167 (52.7%) 57,167 (52.7%)
 Male 51,253 (47.3%) 51,253 (47.3%)
Index year
 2010 19,663 (18.1%) 19,663 (18.1%)
 2011 19,890 (18.3%) 19,890 (18.3%)
 2012 22,538 (20.8%) 22,538 (20.8%)
 2013 22,111 (20.4%) 22,111 (20.4%)
 2014 24,218 (22.3%) 24,218 (22.3%)
Region
 Midwest 27,230 (25.1%) 27,230 (25.1%)
 Northeast 12,826 (11.8%) 12,826 (11.8%)
 South 55,269 (51.0%) 55,269 (51.0%)
 West 13,095 (12.1%) 13,095 (12.1%)
Race
 White 84,613 (78.0%) 84,613 (78.0%)
 Asian 2,742 (2.5%) 2,742 (2.5%)
 Black 8,508 (7.8%) 8,508 (7.8%)
 Hispanic 11,051 (10.2%) 11,051 (10.2%)
 Unknown 1,506 (1.4%) 1,506 (1.4%)
Comorbidities
 Hypertension 66064 (60.9%) 66064 (60.9%)
 Hyperlipidemia 69549 (64.1%) 69549 (64.1%)
 Cardiovascular disease 33418 (30.8%) 33418 (30.8%)
 Diabetes mellitus 30906 (28.5%) 30906 (28.5%)
Insurance type
 Commercial 76697 (70.7%) 76697 (70.7%)
 Medicare Advantage 31723 (29.3%) 31723 (29.3%)